Asst. Prof. Dr. Wiwat Pattanawong

Dr. Asst. Prof. Dr. Wiwat Pattanawong


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Biology
Verified
Journal Article
Open access
PDF file
Korawan SringarmKorawan Sringarm
Korawan Sringarm
MTMarninphan Thongkham
Marninphan Thongkham
SMSupamit Mekchay
Supamit Mekchay
Chompunut LumsangkulChompunut Lumsangkul
Chompunut Lumsangkul
WTWannaluk Thaworn
Wannaluk Thaworn
SHsurat hongsibsong
surat hongsibsong
Sperm sexing technique is favored in the dairy industry. This research focuses on the efficiency of bovine sperm sexing using magnetic-activated cell sorting (MACS) by scFv antibody against Y-chromosome-bearing sperm (Y-scFv) coupled to magnetic microbeads and its effects on kinematic variables, sperm quality, and X/Y-sperm ratio. In this study, the optimal concentration of Y-scFv antibody coupling to the surface of magnetic microbeads was 2–4 mg/mL. PY-microbeads revealed significantly enriched Y-chromosome-bearing sperm (Y-sperm) in the eluted fraction (78.01–81.43%) and X-chromosome-bearing sperm (X-sperm) in the supernatant fraction (79.04–82.65%). The quality of frozen–thawed sexed sperm was analyzed by CASA and imaging flow cytometer, which showed that PY-microbeads did not have a negative effect on X-sperm motility, viability, or acrosome integrity. However, sexed Y-sperm had significantly decreased motility and viability. The X/Y-sperm ratio was determined using an imaging flow cytometer and real-time PCR. PY-microbeads produced sperm with up to 82.65% X-sperm in the X-enriched fraction and up to 81.43% Y-sperm in the Y-enriched fraction. Bovine sperm sexing by PY-microbeads showed high efficiency in separating Y-sperm from X-sperm and acceptable sperm quality. This initial technique is feasible for bovine sperm sexing, which increases the number of heifers in dairy herds while lowering production expenses.

27 March 2025 in Biology
Verified
Journal Article
Open access
PDF file
PTPhacharaporn Tadee
Phacharaporn Tadee
APAsst. Prof. Dr. Wiwat Pattanawong
Asst. Prof. Dr. Wiwat Pattanawong
AMApichart Manwicha
Apichart Manwicha
PKPakasinee Khaodang
Pakasinee Khaodang
DADoungporn Amornlerdpison
Doungporn Amornlerdpison
Pakpoom TadeePakpoom Tadee
Pakpoom Tadee
Mastitis is a major infectious disease that causes significant economic losses in the dairy industry. Current control programs primarily rely on antimicrobials, contributing to the growing concerns of the resistance situation and drug residues in milk. This study aimed to identify the bacterial pathogens responsible for subclinical/clinical bovine mastitis, assess their antimicrobial resistance profiles, and evaluate the antimicrobial effects of Caesalpinia sappan in treating mastitis through both in vitro and in vivo studies. A total of 138 bacterial isolates, representing 40 species, were identified from 100 milk samples collected from dairy cows under the Maejo Cooperative Group in Chiang Mai, Thailand, between May 2021 and February 2022. The most prevalent species was Escherichia coli (10.87%), followed by Bacillus cereus (9.42%) and Staphylococcus sciuri (7.97%). The highest resistance rates were observed for penicillin (65.21%), followed by streptomycin and lincomycin (61.59%). Nine isolates resisted all 18 antimicrobials tested. The average minimum inhibitory concentration (MIC) of C. sappan against the identified pathogens ranged from 0.63 to 17.68 mg/mL, with the highest MIC observed against Pseudomonas luteola. In the animal experiment, treatment with a prototype of an intramammary infusion compound primarily formulated from C. sappan significantly reduced the total bacterial count and California Mastitis Test (CMT) scores (p < 0.01). These results suggest that C. sappan exhibits antimicrobial efficacy against various mastitis bacteria and could serve as a potential alternative treatment to control bovine mastitis in dairy cattle within the study region.

28 August 2023 in Tropical Animal Science Journal
Verified
Journal Article
Open access
PDF file
PPP. Promtan
P. Promtan
JPJ. Panatuk
J. Panatuk
WKW. Kongbuntad
W. Kongbuntad
DAD. Amornlerdpison
D. Amornlerdpison
YNY. Nanta
Y. Nanta
APAsst. Prof. Dr. Wiwat Pattanawong
Asst. Prof. Dr. Wiwat Pattanawong
This research was conducted to investigate the growth performance of black-boned chicken embryonic stem (ES) cells for the future development of cultured meat. Black-boned chicken ES cells were isolated and cultured from fertilized eggs. The treatments applied were: fetal bovine serum (FBS) (T1), commercial chicken serum (SCK) (T2), Pradu Hang Dam chicken serum (PDC) (T3), and black-boned chicken serum (BBC) (T4). Black-boned chicken ES cells were cultured at 37.0 °C in a humidified environment of 5% CO2, for 10 days. The growth of black-boned chicken ES cells concentration was measured by the absorbance at 450 nm. A haemocytometer was used to count the number of black-boned chicken ES cells. Comparing the protein content of cultured meat and chicken meat was collected for combustion and proximate analysis. All collected data were analyzed using ANOVA in a completely randomized design. T4 tended to have a higher number and growth rate than the other groups, followed by T3, T2, and T1, respectively. When counted ES cells final, T4 had a significantly higher number and growth rate than the other groups (p<0.001). Comparing the protein content, it was found that cultured meat had significantly more protein than the other groups (p<0.001), and characteristics (alignment and cross-section of muscle fibers) were not different from chicken cells. Finally, the cultivation of black-boned chicken ES cells necessitates the use of a medium containing black-boned chicken serum in the growth and development of black-boned Chicken ES cells for culture meat.

27 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PTPhacharaporn Tadee
Phacharaporn Tadee
APAsst. Prof. Dr. Wiwat Pattanawong
Asst. Prof. Dr. Wiwat Pattanawong
AMApichart Manwicha
Apichart Manwicha
PKPakasinee Khaodang
Pakasinee Khaodang
DADoungporn Amornlerdpison
Doungporn Amornlerdpison
Pakpoom TadeePakpoom Tadee
Pakpoom Tadee
Mastitis is a major infectious disease that causes significant economic losses in the dairy industry. Current control programs primarily rely on antibiotics, contributing to the growing concerns of antibiotic resistance and drug residues in milk. This study aimed to identify the bacterial pathogens responsible for bovine mastitis, assess their antibiotic resistance profiles, and evaluate the antimicrobial effects of Caesalpinia sappan in treating mastitis through both in vitro and in vivo studies. A total of 138 bacterial isolates representing 40 species were identified from 100 milk samples collected from dairy cows raised under the Maejo Cooperative Group, Chiang Mai, Thailand, between May 2021 and February 2022. The most prevalent species was Escherichia coli (10.87%), followed by Bacillus cereus (9.42%) and Staphylococcus sciuri (7.97%). The highest resistance rates were observed for penicillin (63.04%), followed by streptomycin (60.87%) and lincomycin (57.25%). Nine isolates resisted all 18 antibiotics tested. The minimum inhibitory concentration (MIC) of Caesalpinia sappan against the identified pathogens ranged from 0.63 to 17.68 mg/ml, with the highest MIC observed against Pseudomonas luteola. In the animal experiment, treatment with a prototype of intramammary infusion derived from Caesalpinia sappan with and adding Aloe vera significantly reduced the total bacterial count and California Mastitis Test (CMT) scores (p < 0.01). These results suggest that Caesalpinia sappan exhibit antimicrobial efficacy against various mastitis bacteria and could serve as a potential alternative treatment for managing bovine mastitis in dairy cattle within the study region.